Condition
Non-Seminomatous Germ Cell Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Non-Seminomatous Germ Cell Tumor clinical trials that are recruiting, at sites in 2 countries (most in France (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Validation of a treatment approach for poor-risk non-seminomatous germ cell tumors
This study is testing a personalized treatment plan for young adults with hard-to-treat non-seminomatous germ cell tumors to see if it improves their outcomes based on how their tumor markers respond to chemotherapy.
-
Oral etoposide versus observation after high-dose chemotherapy for relapsed germ cell tumors
This study is testing if taking daily oral etoposide after high-dose chemotherapy can help people with relapsed germ cell tumors do better than just watching and waiting.
Related topics
Quick answers
How many Non-Seminomatous Germ Cell Tumor clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.